AnaSpec and Cyclex Sign Licensing Agreement for Deacetylase Activity Assay Kits
News Sep 15, 2008
AnaSpec and Cyclex Co. Ltd. have announced a licensing agreement that will allow AnaSpec to make, use, and sell deacetylase activity assay kits and the related products as covered by Cyclex’s patent.
"We are pleased to partner with Cyclex in expanding our array of next generation assay kits," noted Dr. Anita Hong, AnaSpec's president.
"The new SensoLyte™ HDAC assay kits will provide our customers with new long wavelength options for the detection of histone deacetylase activity. AnaSpec also plans to develop other long wavelength HDAC related kits including SIRT assay kits."
Mechanism by Which Alpha Synuclein Causes Cell Death in Parkinson's IdentifiedNews
Detailed brain cell analysis has helped researchers uncover new mechanisms thought to underlie Parkinson's disease.READ MORE